- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02531139
The Effect of Blood Pressure on Cerebral Perfusion During Vascular Surgery
The Effect of Blood Pressure on Cerebral Perfusion and Oxygenation During Vascular Surgery
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Background: Induction of anesthesia reduces mean arterial pressure (MAP) and cerebral blood flow is normally considered to be maintained by cerebral autoregulation despite changes in MAP between 60 - 150 mmHg and standard of care during anesthesia is to maintain MAP above 60 mmHg. Vascular surgical patients are often elderly with hypertension and atherosclerotic manifestations that may impair cerebral autoregulation of importance for anesthesia-induced reduction in blood pressure.
Objective: To assess the effect of MAP for preservation of cerebral blood flow and oxygenation during vascular surgery.
Hypothesis: The primary hypothesis is that during general anesthesia in vascular surgical patients, cerebral blood flow velocity and oxygenation is higher with MAP maintained at 80-90 mmHg, compared with a MAP maintained at a minimum of 60 mmHg.
MAP is controlled in both groups using continuous infusion of phenylephrine. Phenylephrine is used as a tool in order to assess the effect of MAP on the cerebral circulation. In both groups, central blood volume is optimized by infusion of lactated Ringer´s solution using a goal directed fluid therapy following induction of anaesthesia and before commencement of phenylephrine infusion.
Trial size: The investigators will include 40 participants (2 x 20) in order to detect or reject a 20% difference in middle cerebral artery velocity with a type I error risk of 5% and a type II error risk of 20% (power at 80%). Interim analysis will be conducted after inclusion of 20 patients (2 x 10). Excluded patients will be replaced.
Undersøgelsestype
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Copenhagen Ø, Danmark, 2100
- Rigshospitalet, Anæstesi og Operationsklinikken 2043
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patients undergoing one of the following vascular surgical interventions in general anesthesia: Infra-inguinal bypass, femoro-femoral cross-over bypass or iliofemoral bypass surgery.
- Age > 18 years. Informed consent
Exclusion Criteria:
- Use of monoamine oxidase inhibitors
- Allergy to phenylephrine
- Patients that cannot cooperate during examination
- Dementia defined as Mini-Mental State Examination < 24
- Anesthesia within the last 30 days
- Alcohol consumption at or above 420 grams per week
- Lack of fluency in written and spoken Danish
- Severe hearing and vision impairment
- Neurological disease
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Tredobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: MAP maintained at 80 mmHg
During anesthesia MAP is maintained at 80 - 90 mmHg MAP using continuous infusion of phenylephrine.
|
Intervention group, MAP is maintained at 80 - 90 mmHg during anesthesia using continuous infusion of phenylephrine.
|
Aktiv komparator: MAP maintained at 60 mmHg
During anesthesia MAP is maintained at minimum of 60 mmHg using continuous infusion of phenylephrine.
|
Control group, MAP is maintained at minimum of 60 mmHg during anesthesia using continuous infusion of phenylephrine.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Middle cerebral artery blood velocity
Tidsramme: During surgery
|
Middle cerebral artery blood velocity measured in [cm/s] assessed by transcranial Doppler.
Changes in middle cerebral artery blood velocity reflects changes in cerebral blood flow.
|
During surgery
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Change in serum S100B as compared between subjects in the control- and intervention groups
Tidsramme: Blood is sampled 10 min prior to induction of anesthesia and at the end of surgery
|
Serum concentrations of S100B, a marker of neuronal injury
|
Blood is sampled 10 min prior to induction of anesthesia and at the end of surgery
|
Change in serum neuron-specific enolase as compared between subjects in the control- and intervention groups
Tidsramme: Blood is sampled 10 min prior to induction of anesthesia and at the end of surgery
|
Serum concentrations of neuron-specific enolase, a marker of neuronal injury
|
Blood is sampled 10 min prior to induction of anesthesia and at the end of surgery
|
Regional cerebral oxygenation as compared between subjects in the control- and intervention groups
Tidsramme: During surgery
|
Frontal lobe oxygenation measured as the percentage of oxyhemoglobin of total hemoglobin [%] evaluated by near-infrared spectroscopy
|
During surgery
|
Cardiac output as compared between subjects in the control- and intervention groups
Tidsramme: During surgery
|
Cardiac output measured in [l/min] evaluated by pulse contour analysis of the arterial blood pressure curve
|
During surgery
|
Stroke volume as compared between subjects in the control- and intervention groups
Tidsramme: During surgery
|
Stroke volume measured in [ml/min] evaluated by pulse contour analysis of the arterial blood pressure curve
|
During surgery
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Niels D. Olesen, MD, Rigshospitalet, Anæstesi og Operationsklinikken 2043, Denmark
Datoer for undersøgelser
Studer store datoer
Studiestart (Forventet)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- NDOlesen
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Anæstesi
-
Postgraduate Institute of Medical Education and...AfsluttetAnæstesi | Closed Loop Anesthesia Delivery System (CLADS)Indien
-
Ohio State UniversityBaxter Healthcare CorporationAfsluttetSevofluran | Cystoskoper | Baxter Anesthesia Brand af DesfluraneForenede Stater
Kliniske forsøg med MAP maintained at 80 mmHg
-
Rigshospitalet, DenmarkAfsluttetGastrointestinale neoplasmer | Anæstesi, generalDanmark
-
Shanghai Jiao Tong University School of MedicineAfsluttetVævsekspanderforstyrrelseKina
-
Sahlgrenska University Hospital, SwedenAfsluttetSeptisk chok | Akut nyreskadeSverige
-
Centre Hospitalier le MansRekrutteringHjertestop | Iskæmisk reperfusionsskade | Cerebral læsion | Iskæmisk encefalopatiFrankrig
-
University Hospital, AngersRekruttering
-
Université de SherbrookeAktiv, ikke rekrutterendeHypotension | Sædvanlig pleje | Vasopressorer | Gennemsnitlige arterielle trykmålCanada
-
University Hospital, AngersIkke rekrutterer endnu
-
University of Southern DenmarkRekrutteringIntensivafdeling | Hjertestop uden for hospitalet | Mekanisk ventilation | Genoplivning | Iltterapi | Hypertension, pulmonal arterielDanmark
-
Jesper KjaergaardOdense University HospitalAfsluttetBlodtryk | Hjertestop uden for hospitalet | Hæmodynamisk ustabilitetDanmark
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)AfsluttetPatienter med koronararterie-bypassgraftkirurgiForenede Stater